Skip to content

Clinical, Radiographic, and Histological evaluation of deproteinization demineralized tooth matrix (dpDTM) as bone grafting material for alveolar ridge preservation

Clinical, Radiographic, and Histological evaluation of deproteinization demineralized tooth matrix (dpDTM) as bone grafting material for alveolar ridge preservation

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200928002
Enrollment
30
Registered
2020-09-28
Start date
2022-03-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Alveolar ridge preservation with dpDTM and FGG ,Alveolar ridge preservation with FDBA and FGG ,Alveolar ridge preservation with FGG
dpDTM and FGG ,FDBA and FGG ,FGG

Sponsors

Ministry of Higher Education, Science, Research and Innovation, Prince of Songkla University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Adults patients (> 20 years old) requiring extraction of one upper or lower single root tooth (incisor, canine, and premolar) in Elien socket classification l and ll. 2. The patient can sign the consent form to participate in the study and able to follow up on the appointment. 3. Patients requiring dental implant treatment. 4.Presence of adjacent (mesial and/or distal) natural teeth. 5. Systemically healthy patients and cessation of smoking for 1 week before and 8 weeks after initial implant placement. 6. No contraindication for minor oral surgery.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of malignancy, radiotherapy or chemotherapy for treatment of malignancy. 2. Pregnant patient or intending to become pregnant or nursing at the time of study inclusion. 3. Patients taking medications or having treatments with an effect on healing in general e.g. steroids, large doses of anti-inflammatory drugs, and bisphosphonates 4. Patients have an active infection in the area of study. 5. Patients have severe periodontal disease.

Design outcomes

Primary

MeasureTime frame
Dimensional change of alveolar ridge width and height immediate post operative and 3 months post operative Radiographic

Secondary

MeasureTime frame
The secondary outcomes were soft and hard tissue volume reductions, implant stability, and bone formation. immediate post operative and 3 months post operative. Soft tissue volume reduction with Geomagic program, Hard tissue volume reduction with ITK snap program. Implant stability with RFA, bone formation from histology and microCT

Countries

Thailand

Contacts

Public ContactSrisurang Suttapreyasri

Prince of Songkla University

srisurang.s@psu.ac.th0879790055

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026